To include your compound in the COVID-19 Resource Center, submit it here.

Keryx raises $33 million

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) raised $33 million through the sale

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE